Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Loteprednol vs Prednisolone after Endothelial Keratoplasty
NCT01853696Phase 4Completed
- Sponsor
- Cornea Research Foundation of America
- Start
- Mar 2013
- Primary completion
- Jan 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of loteprednol etabonate in corneal graft rejection (CGR), sponsored by Cornea Research Foundation of America. Started Mar 2013; status: completed.
02
Drugs
loteprednol etabonate
03
Conditions
corneal graft rejection (CGR)
Beyond the preview
Go deeper on NCT01853696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01853696.